Discover how Flexible Heteroarotinoids (Flex-Hets) represent a breakthrough in cancer treatment with selective targeting and minimal side effects.
Discover how monodisperse, shape-specific nanobiomaterials are transforming cancer therapeutics and imaging through unprecedented precision targeting.
Explore how graft copolymers with tunable amphiphilicity are transforming cancer treatment through efficient dual drug delivery systems.
Explore how multivariate modulation of Zr MOF UiO-66 enables defect-controlled combination anticancer drug delivery for precision medicine.
Explore the revolutionary promise of magnetic upconversion nanoscale metal-organic frameworks (MOF composites) in cancer therapy - targeted, precise treatment that diagnoses and destroys cancer cells.
Discover how iota carrageenan-barium nanoparticles are transforming cancer diagnosis and treatment through selective targeting and imaging capabilities.
Breakthrough research on triazole-fused pyrimidine derivatives as potent LSD1 inhibitors for epigenetic cancer therapy, particularly in acute myeloid leukemia.
Explore the revolutionary ARX-788 antibody-drug conjugate, a precision cancer treatment targeting HER2-positive cancers with unprecedented accuracy and efficacy.
Discover how new research is transforming 5-FU cancer treatment through pharmacokinetic reevaluation, improving safety and efficacy.
Explore how porous silicon nanoparticles are transforming cancer treatment through precise siRNA delivery and gene silencing technology.